One of the nation’s leading cancer research and treatment centers, the UAB Comprehensive Cancer Center is the only NCI-designated comprehensive cancer center located in a six-state area that includes Alabama, Mississippi, Louisiana, Arkansas, South Carolina, and Georgia.
From bench to bedside, the UAB Comprehensive Cancer Center is at the forefront of improving cancer prevention, diagnosis, and treatment, and researchers here have pioneered advances in chemotherapy, surgery, radiotherapy, immunotherapy, and nutrition.
The UAB Comprehensive Cancer Center is recognized around the world as a leader in developing innovative monoclonal antibody approaches to cancer therapy. The Center conducts clinical trials using genetically engineered monoclonal antibodies alone or armed with a payload of immunotoxins, chemotherapy drugs, or radioactive isotopes to specifically target a broad array of cancers, including breast, gastrointestinal tract, lung, ovary, head and neck, brain tumors, and lymphomas.
The UAB Comprehensive Cancer Center offers a full array of treatment options from interdisciplinary clinics to the latest techniques in bone marrow transplantation. It has an outstanding faculty of 350 physicians and researchers, many of whom are internationally and nationally recognized for their expertise in oncology. The UAB program in Supportive and Palliative Medicine is among the foremost in the nation. The Center treats an estimated 5,000 new patients each year and provides ongoing care for more than 20,000 patients annually.